Assay employing sacs and sac lysing agent

Claim 2

An assay for an analyte, comprising: contacting tracer and analyte with a binder for at least the analyte, said tracer comprising a ligand coupled to a sac lysing agent, said ligand portion of the tracer becoming bound by one of the analyte and binder, whereby a portion of the tracer is bound to the binder; contacting unbound tracer with sacs, at least a portion of said sacs including in the interior thereof a detectable marker and at least a portion of the sacs including a sac lysing agent in an inactive form and which is active when released from the sacs; and determining marker released from the sacs as a measure of analyte.

Claim 3

The assay of claim 1 wherein at least a portion of the sacs include both the detectable marker and the lysing agent in the interior thereof.

Claim 4

The assay of claim 2 wherein the sacs are liposomes.

Claim 5

The assay of claim 3 wherein the lysing agent is an enzyme and the enzyme in the interior of the sacs is in an inactive form.

Claim 6

The assay of claim 1 wherein the binder is supported on a solid support.

Claim 7

The assay of claim 5 wherein the binder is a binder for both the analyte and tracer.

Claim 8

The assay of claim 6 wherein bound and free tracer portions are not separated prior to release of the marker whereby the assay is a homogeneous assay.

Claim 9

The assay of claim 5 wherein the detectable marker is a non-isotopic marker.

Claim 10

The assay of claim 2 wherein the analyte is a hapten.

Claim 11

The assay of claim 9 wherein the analyte is in a sample of a body fluid.

Claim 12

An assay for an analyte comprising: contacting tracer and analyte with a binder for at least the analyte, said tracer comprising a ligand coupled to active liposome lysing agent comprising an enzyme, said ligand portion of the tracer becoming bound by one of the binder and analyte, whereby a portion of the tracer is bound by the binder; contacting unbound tracer with liposomes containing in the interior therein a non-isotopic detectable marker and a liposome lysing agent comprising an enzyme in inactive form, said contacting with the liposomes being effected in the presence of an activating agent for the liposome lysing agent within the liposomes whereby detectable marker is released from the lysed liposomes and liposome lysing agent released from the liposomes is active for lysing additional liposomes to provide a cascading effect; and determining released marker as a measure of analyte.

Claim 13

An assay for an analyte comprising: contacting tracer and analyte with a binder for at least the analyte, said tracer comprising a ligand coupled to active liposome lysing agent comprising an enzyme, said ligand portion of the tracer becoming bound by one of the binder and analyte, whereby a portion of the tracer is bound by the binder; contacting unbound tracer with liposomes containing in the interior therein a non-isotopic detectable marker and a liposome lysing agent comprising an enzyme in inactive form, said contacting with the liposomes being effected in the presence of an activating agent for the liposome lysing agent within the liposomes whereby detectable marker is released from the lysed liposomes and liposome lysing agent released from the liposomes is active for lysing additional liposomes to provide a cascading effect; and determining released marker as a measure of analyte.

Claim 14

The assay of claim 11 wherein the interior of the liposome includes a calcium dependent enzyme lysing agent and a calcium complexing agent to inactivate the enzyme lysing agent within the liposome, and the activating agent comprises calcium in an amount sufficient to activate released lysing agent.

Claim 15

The assay of claim 11 wherein the interior of the liposome includes an apo-enzyme and the activating agent is a coenzyme.

Claim 16

The assay of claim 11 wherein the binder is supported on a solid support.

Claim 17

The assay of claim 11 wherein the analyte is determined in a body fluid.

Claim 18

The assay of claim 15 wherein bound and free tracer portions are not separated prior to release of the marker whereby the assay is a homogeneous assay.

Claim 19

The assay of claim 16 wherein the analyte is a hapten.

Claim 20

A reagent kit for an assay for an analyte, comprising: a package, said package containing (a) a tracer comprising a ligand coupled to a sac lysing agent; and (b) sacs, at least a portion of the sacs, containing in the interior thereof a sac lysing agent in an inactive form and at least a portion of the sacs containing in the interior thereof a detectable marker.

Claim 21

A reagent kit for an assay for an analyte, comprising: a package, said package containing (a) a tracer comprising a ligand coupled to a sac lysing agent; and (b) sacs, at least a portion of the sacs, containing in the interior thereof a sac lysing agent in an inactive form and at least a portion of the sacs containing in the interior thereof a detectable marker.

Claim 22

The kit of claim 18 wherein the sacs contain both the sac lysing agent, in inactive form, and the detectable marker in the interior thereof, said detectable marker being a non-isotopic marker.

Claim 23

The kit of claim 18 wherein the sacs are liposomes.

Claim 24

The kit of claim 20 wherein the package further contains a binder for at least the analyte, said ligand portion of the tracer being bound by the binder.

Claim 25

The kit of claim 21 wherein the lysing agent is an enzyme and the enzyme in the interior of the sacs is in an inactive form.

Claim 26

The kit of claim 22 wherein the enzyme lysing agent in the liposome is a calcium dependent enzyme and the interior of the liposome further contains a calcium complexing agent to inactivate the enzyme.

Claim 27

The kit of claim 18 wherein the package further contains a binder for the analyte, standard solutions of the analyte and an activating buffer for the sac lysing agent in the interior of the sacs.